Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine in schizophrenia

J Hietala1, E Syvälahti

  • 1Department of Psychiatry, Turku University Central Hospital, Finland.

Annals of Medicine
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

The dopamine (DA) hypothesis of schizophrenia is complex, with current evidence suggesting multiple neurotransmitter imbalances. Dopamine D2 receptor blockade remains key for antipsychotic drug action in schizophrenia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of childhood physical abuse on social anxiety is mediated via reduced frontal lobe and amygdala-hippocampus complex volume in adult clinical high-risk subjects.

Schizophrenia research·2020
Same author

Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.

European journal of pain (London, England)·2017
Same author

Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies.

European psychiatry : the journal of the Association of European Psychiatrists·2015
Same author

Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project.

European psychiatry : the journal of the Association of European Psychiatrists·2013
Same author

First measurement of the form factors in the decays D0 → ρ- e+ ν(e) and D+ → ρ0 e+ ν(e).

Physical review letters·2013
Same author

Prediction of psychosis in clinical high-risk patients by the Schizotypal Personality Questionnaire. Results of the EPOS project.

European psychiatry : the journal of the Association of European Psychiatrists·2013

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • The dopamine (DA) hypothesis of schizophrenia has evolved significantly over time.
  • Schizophrenia is a complex, heterogeneous disorder, unlikely to be explained by a single neurotransmitter hypothesis.
  • Aberrant neuronal circuit connections and imbalances are implicated in schizophrenia's neurophysiology.

Purpose of the Study:

  • To review the current understanding of the dopamine hypothesis in schizophrenia.
  • To evaluate the role of dopamine in the neurobiology of schizophrenia and antipsychotic drug action.
  • To highlight future research directions for investigating dopamine's role.

Main Methods:

  • Review of existing literature on the dopamine hypothesis of schizophrenia.

Related Experiment Videos

  • Analysis of neuroimaging studies in neuroleptic-naive schizophrenia patients.
  • Discussion of the mechanism of action of antipsychotic drugs, particularly dopamine D2 receptor blockade.

    • Main Results:

    • Dopamine is likely involved in schizophrenia, supported by neuroimaging in drug-naive patients.
    • The dopamine hypothesis of neuroleptic drug action is well-supported, with D2 receptor blockade being a primary mechanism.
    • Complex imbalances in neuronal circuits, not just dopamine, likely underlie schizophrenia.

    Conclusions:

    • While the overall dopamine hypothesis of schizophrenia is debated, dopamine D2 receptor blockade is a validated therapeutic target.
    • Future research should focus on neuroleptic-naive, first-episode schizophrenia patients to elucidate specific dopaminergic pathway changes.
    • Understanding these changes may link dopaminergic function to specific psychopathological dimensions in schizophrenia.